Population-based analysis of class effect of β blockers in heart failure

American Journal of Cardiology

Volumn 107, Issue 8, 2011, Pages 1196-1202

  Lazarus, Darius Lucian ^a,b   Jackevicius, Cynthia Anne ^c,d,e   Behlouli, Hassan ^b   Johansen, Helen ^f   Pilote, Louise ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f STATISTICS CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; METOLAZONE; METOPROLOL; NITRATE; SOTALOL; SPIRONOLACTONE; TICLOPIDINE; WARFARIN;

AGED; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; POPULATION SURVEILLANCE; QUEBEC; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79953248730     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.12.017     Document Type: Article

References (29)

1. Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
2. A. Hjalmarson, S. Goldstein, B. Fagerberg, H. Wedel, F. Waagstein, J. Kjekshus, J. Wikstrand, D. El Allaf, J. Vitovec, J. Aldershvile, M. Halinen, R. Dietz, K.L. Neuhaus, A. Janosi, G. Thorgeirsson, P.H. Dunselman, L. Gullestad, J. Kuch, J. Herlitz, P. Rickenbacher, S. Ball, S. Gottlieb, P.S. Deedwania MERIT-HF Study Group Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF) JAMA 283 2000 1295 1302 (Pubitemid 30129796)
3. W.S. Colucci, M. Packer, M.R. Bristow, E.M. Gilbert, J.N. Cohn, M.B. Fowler, S.K. Krueger, R. Hershberger, B.F. Uretsky, J.A. Bowers, J.D. Sackner-Bernstein, S.T. Young, T.L. Holcslaw, M.A. Lukas US Carvedilol Heart Failure Study Group Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure Circulation 94 1996 2800 2806 (Pubitemid 26411744)
4. M.R. Bristow, E.M. Gilbert, W.T. Abraham, K.F. Adams, M.B. Fowler, R.E. Hershberger, S.H. Kubo, K.A. Narahara, H. Ingersoll, S. Krueger, S. Young, N. Shusterman MOCHA Investigators Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure Circulation 94 1996 2807 2816 (Pubitemid 26411745)
5. M. Packer, W.S. Colucci, J.D. Sackner-Bernstein, C.S. Liang, D.A. Goldscher, I. Freeman, M.L. Kukin, V. Kinhal, J.E. Udelson, M. Klapholz, S.S. Gottlieb, D. Pearle, R.J. Cody, J.J. Gregory, N.E. Kantrowitz, T.H. LeJemtel, S.T. Young, M.A. Lukas, and N.H. Shusterman Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise Circulation 94 1996 2793 2799 (Pubitemid 26411743)
6. M. Packer, M. Packer, M.R. Bristow, J.N. Cohn, W.S. Colucci, M.B. Fowler, E.M. Gilbert, and N.H. Shusterman The effect of carvedilol on morbidity and mortality in patients with chronic heart failure U.S. Carvedilol Heart Failure Study Group N Engl J Med 334 1996 1349 1355 (Pubitemid 26152713)
7. M. Packer, A.J. Coats, M.B. Fowler, H.A. Katus, H. Krum, P. Mohacsi, J.L. Rouleau, M. Tendera, A. Castaigne, E.B. Roecker, M.K. Schultz, and D.L. DeMets Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658 (Pubitemid 32479962)
8. M. Packer, M.B. Fowler, E.B. Roecker, A.J. Coats, H.A. Katus, H. Krum, P. Mohacsi, J.L. Rouleau, M. Tendera, C. Staiger, T.L. Holcslaw, I. Amann-Zalan, and D.L. DeMets Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study Circulation 106 2002 2194 2199 (Pubitemid 35222212)
9. CIBIS Investigators and Committees A randomized trial of beta-blockade in heart failure The Cardiac Insufficiency Bisoprolol Study (CIBIS) Circulation 90 1994 1765 1773
10. P. Lechat, P. Lechat, S. Escolano, J.L. Golmard, H. Lardoux, S. Witchitz, J.A. Henneman, B. Maisch, M. Hetzel, P. Jaillon, J.P. Boissel, and A. Mallet Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS) Circulation 96 1997 2197 2205 (Pubitemid 27425823)
11. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) a randomised trial Lancet 353 1999 9 13
12. A. Leizorovicz, P. Lechat, M. Cucherat, and F. Bugnard Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studiesCIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study Am Heart J 143 2002 301 307
13. J.M. Brophy, L. Joseph, and J.L. Rouleau Beta-blockers in congestive heart failure A Bayesian meta-analysis Ann Intern Med 134 2001 550 560 (Pubitemid 32245316)
14. J.M. Foody, M.H. Farrell, and H.M. Krumholz Beta-Blocker therapy in heart failure: scientific review JAMA 287 2002 883 889 (Pubitemid 34252037)
15. F. Waagstein, M.R. Bristow, K. Swedberg, F. Camerini, M.B. Fowler, M.A. Silver, E.M. Gilbert, M.R. Johnson, F.G. Goss, A. Hjalmarson Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy Lancet 342 1993 1441 1446 (Pubitemid 24000287)
16. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, T.G. Ganiats, M. Jessup, M.A. Konstam, D.M. Mancini, K. Michl, J.A. Oates, P.S. Rahko, M.A. Silver, L.W. Stevenson, and C.W. Yancy Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
17. Heart Failure Society of America Executive summary: HFSA 2006 comprehensive heart failure practice guideline J Card Fail 12 2006 10 38
18. Heart Failure Society of America HFSA 2006 comprehensive heart failure practice guideline J Card Fail 12 2006 e1 e2
19. J.M. Arnold, P. Liu, C. Demers, P. Dorian, N. Giannetti, H. Haddad, G.A. Heckman, J.G. Howlett, A. Ignaszewski, D.E. Johnstone, P. Jong, R.S. McKelvie, G.W. Moe, J.D. Parker, V. Rao, H.J. Ross, E.J. Sequeira, A.M. Svendsen, K. Teo, R.T. Tsuyuki, M. White Canadian Cardiovascular Society Consensus conference recommendations on heart failure 2006: diagnosis and management Can J Cardiol 22 2006 23 45
20. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, P.A. Poole-Wilson, A. Stromberg, D.J. van Veldhuisen, D. Atar, A.W. Hoes, A. Keren, A. Mebazaa, M. Nieminen, S.G. Priori, K. Swedberg, A. Vahanian, J. Camm, R. De Caterina, V. Dean, C. Funck-Brentano, I. Hellemans, S.D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, and J.L. Zamorano ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
21. P. Jong, E. Vowinckel, P.P. Liu, Y. Gong, and J.V. Tu Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study Arch Intern Med 162 2002 1689 1694
22. C. Repchinsky Compendium of Pharmaceuticals and Specialties 2008 ed. 2008 Canadian Pharmacists Association Ottawa
23. D. Cox Regression models and life-tables J R Stat Soc B Stat Methodol 34 1972 187 220
24. P.A. Poole-Wilson, K. Swedberg, J.G. Cleland, A. Di Lenarda, P. Hanrath, M. Komajda, J. Lubsen, B. Lutiger, M. Metra, W.J. Remme, C. Torp-Pedersen, A. Scherhag, and A. Skene Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 2003 7 13 (Pubitemid 36835815)
25. W.J. Remme, C. Torp-Pedersen, J.G. Cleland, P.A. Poole-Wilson, M. Metra, M. Komajda, K. Swedberg, A. Di Lenarda, P. Spark, A. Scherhag, C. Moullet, and M.A. Lukas Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET J Am Coll Cardiol 49 2007 963 971 (Pubitemid 46335773)
26. A.S. Go, J. Yang, J.H. Gurwitz, J. Hsu, K. Lane, and R. Platt Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice Arch Intern Med 168 2008 2415 2421
27. J.M. Kramer, L.H. Curtis, C.S. Dupree, D. Pelter, A. Hernandez, M. Massing, and K.J. Anstrom Comparative effectiveness of beta-blockers in elderly patients with heart failure Arch Intern Med 168 2008 2422 2432
28. S. Rinfret, M. Abrahamowicz, J. Tu, K. Humphries, M.J. Eisenberg, H. Richard, P.C. Austin, and L. Pilote A population-based analysis of the class effect of beta-blockers after myocardial infarction Am Heart J 153 2007 224 230 (Pubitemid 46096869)
29. P.C. Austin, P.A. Daly, and J.V. Tu A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario Am Heart J 144 2002 290 296 (Pubitemid 34879653)